Y. Lecrubier

33.1k total citations · 4 hit papers
194 papers, 26.6k citations indexed

About

Y. Lecrubier is a scholar working on Psychiatry and Mental health, Pharmacology and Experimental and Cognitive Psychology. According to data from OpenAlex, Y. Lecrubier has authored 194 papers receiving a total of 26.6k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Psychiatry and Mental health, 62 papers in Pharmacology and 55 papers in Experimental and Cognitive Psychology. Recurrent topics in Y. Lecrubier's work include Treatment of Major Depression (59 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (43 papers) and Schizophrenia research and treatment (34 papers). Y. Lecrubier is often cited by papers focused on Treatment of Major Depression (59 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (43 papers) and Schizophrenia research and treatment (34 papers). Y. Lecrubier collaborates with scholars based in France, United States and United Kingdom. Y. Lecrubier's co-authors include David V. Sheehan, E. Weiller, Patrícia Brandão Amorim, T. Hergueta, Robert A. Baker, Kathy H. Sheehan, A Keskiner, John A. Schinka, Hans‐Ulrich Wïttchen and T. Bedirhan Üstün and has published in prestigious journals such as American Journal of Psychiatry, Biological Psychiatry and The British Journal of Psychiatry.

In The Last Decade

Y. Lecrubier

193 papers receiving 25.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10.

1998 8.9k citations Y. Lecrubier et al. PubMed profile →
The mini international neuropsychiatric interview

1998 5.2k citations Y. Lecrubier, E. Weiller et al. European Psychiatry profile →
The Mini International Neuropsychiatric Interview (MINI). A short diagnostic structured interview: reliability and validity according to the CIDI

1997 2.9k citations Y. Lecrubier, E. Weiller et al. European Psychiatry profile →
The validity of the Mini International Neuropsychiatric Interview (MINI) according to the SCID-P and its reliability

1997 1.7k citations Y. Lecrubier, E. Weiller et al. European Psychiatry profile →

Peers

Countries citing papers authored by Y. Lecrubier

Since Specialization

Citations

This map shows the geographic impact of Y. Lecrubier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y. Lecrubier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y. Lecrubier more than expected).

Fields of papers citing papers by Y. Lecrubier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y. Lecrubier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y. Lecrubier. The network helps show where Y. Lecrubier may publish in the future.

Co-authorship network of co-authors of Y. Lecrubier

This figure shows the co-authorship network connecting the top 25 collaborators of Y. Lecrubier. A scholar is included among the top collaborators of Y. Lecrubier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y. Lecrubier. Y. Lecrubier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Dysbindin gene (DTNBP1) in major depressive disorder (MDD) patients: Lack of association with clinical phenotypes 2010 ·The World Journal of Biological Psychiatry ·Neslihan Aygün Kocabaş, Irina Antonijevic, (unknown), Carlos Forray, Siegfried Kasper, Y. Lecrubier, Sylvie Linotte, Isabelle Massat, Stuart Montgomery, (unknown), Pierre Oswald, Lenore Snyder, Daniel Souery, Joseph Zohar, Julien Mendlewicz	3
2	Brain-derived neurotrophic factor gene polymorphisms 2010 ·International Clinical Psychopharmacology ·Neslihan Aygün Kocabaş, Irina Antonijevic, (unknown), Carlos Forray, Siegfried Kasper, Y. Lecrubier, Sylvie Linotte, Isabelle Massat, Julien Mendlewicz, (unknown), Stuart Montgomery, Pierre Oswald, Lenore Snyder, Joseph Zohar, Daniel Souery	66
3	5HT1A and 5HT2A receptor genes in treatment response phenotypes in major depressive disorder 2010 ·International Clinical Psychopharmacology ·(unknown), Irina Antonijevic, Carlos Forray, Siegfried Kasper, Neslihan Aygün Kocabaş, Y. Lecrubier, Sylvie Linotte, Julien Mendlewicz, Stuart Montgomery, Lenore Snyder, Daniel Souery, Paul Verbanck, Joseph Zohar, Isabelle Massat	34
4	Identification of clinical factors associated with resistance to antidepressants in bipolar depression: results from an European Multicentre Study 2010 ·International Clinical Psychopharmacology ·Julien Mendlewicz, Isabelle Massat, Sylvie Linotte, Siegfried Kasper, Anastasios Konstantinidis, Y. Lecrubier, Stuart Montgomery, Alessandro Serretti, Joseph Zohar, Daniel Souery	16
5	Consensus Statement on the Benefit to the Community of ESEMeD Survey Data on Depression and Anxiety 2007 ·The Journal of Clinical Psychiatry ·DJ Nutt, RC Kessler, (unknown), (unknown), Y. Lecrubier, (unknown), David Mechanic, André Tylee	0
6	Clinical Factors Associated With Treatment Resistance in Major Depressive Disorder 2007 ·The Journal of Clinical Psychiatry ·Daniel Souery, Pierre Oswald, Isabelle Massat, Ursula F. Bailer, (unknown), Koen Demyttenaere, Siegfried Kasper, Y. Lecrubier, Stuart Montgomery, Alessandro Serretti, Joseph Zohar, Julien Mendlewicz, (unknown)	371
7	Awareness of Metabolic Concerns in Patients With Bipolar Disorder: A Survey of European Psychiatrists 2007 ·European Psychiatry ·Michael Bauer, Y. Lecrubier, Trisha Suppes	26
8	Qualitative changes in symptomatology before and after treatment to remission in generalised anxiety disorder and major depression 2006 ·ePrints Soton (University of Southampton) ·Y. Lecrubier, E. Weiller, Henning Andersen, David S. Baldwin	2
9	Efficacy of St. John’s Wort Extract WS 5570 in Major Depression: A Double-Blind, Placebo-Controlled Trial 2002 ·American Journal of Psychiatry ·Y. Lecrubier, G. Clerc, (unknown), Meinhard Kieser	132
10	Consensus statement on depression, anxiety, and functional gastrointestinal disorders. 2001 ·PubMed ·J.C. Ballenger, Jonathan Davidson, Y. Lecrubier, David Nutt, (unknown), Emeran A. Mayer	24
11	Social phobia: diagnosis and epidemiology, neurobiology and pharmacology, comorbidity and treatment 2000 ·Journal of Affective Disorders ·N. Brunello, (unknown), (unknown), Siegfried Kasper, (unknown), Malcolm Lader, Y. Lecrubier, J Lépine, R. Bruce Lydiard, J. Mendlewicz, S.A. Montgomery, Giorgio Racagni, (unknown), Hans‐Ulrich Wïttchen	112
12	Amisulpride versus Amineptine and Placebo for the Treatment of Dysthymia 1999 ·Neuropsychobiology ·P Boyer, Y. Lecrubier, (unknown), O. Fleurot	85
13	[Schizophrenia, from classification to dimensions: value of longitudinal studies]. 1997 ·PubMed ·Y. Lecrubier	1
14	Dysthymia in neurological disorders. 1996 ·PubMed ·H.S. Akiskal, (unknown), C. L. Cazzullo, (unknown), Valentim Gentil, Y. Lecrubier, Julio Licínio, Martial Van der Linden, J. J. López-Ibor, (unknown), Luca Pani, L. L. Prilipko, Mary M. Robertson, R G Robinson, (unknown), Peter Thomas, Yun Wang, Ma‐Li Wong	11
15	Social Phobia in General Health Care: An Unrecognised Undertreated Disabling Disorder 1996 ·The British Journal of Psychiatry ·E. Weiller, J.C. Bisserbe, Pascal Boyer, J. P. Lépine, Y. Lecrubier	180
16	Recurrent Brief Depression: Clinical and Epidemiological Issues 1995 ·Psychopathology ·(unknown), Antoine Pélissolo, Emmanuelle Weiller, (unknown), Y. Lecrubier	10
17	Clonidine and Neuroleptic-Resistant Mania 1988 ·The British Journal of Psychiatry ·Roland Jouvent, Y. Lecrubier, (unknown), Daniel Widlöcher	4
18	Favourable effects of yohimbine on clomipramine‐induced orthostatic hypotension: a double‐blind study. 1981 ·British Journal of Clinical Pharmacology ·Y. Lecrubier, Puech Aj, Austin Des Lauríers	14
19	[A new approach to the treatment of depression: salbutamol]. 1978 ·PubMed ·Daniel Widlöcher, Pierre Simon, J.‐F. Allilaire, Roland Jouvent, Y. Lecrubier, Alain Puech	5
20	[Study of a beta-adrenergic stimulant and its antidepressant activity in man]. 1977 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Roland Jouvent, Y. Lecrubier, Puech Aj, (unknown), Daniel Widlöcher	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact